Lack of congruence ofS-carboxymethyl-L-cysteine sulphoxidation and debrisoquine 4-hydroxylation in a Caucasian population
- 1 January 1985
- journal article
- research article
- Published by Taylor & Francis in Xenobiotica
- Vol. 15 (5) , 445-450
- https://doi.org/10.3109/00498258509045015
Abstract
1. One-hundred-and-twenty volunteers and three families were investigated for possible association between the sulphoxidation of S-carboxymethyl-L-cysteine and the debrisoquine hydroxylation polymorphism. 2. The observed individual variations in these two metabolic reactions were shown not to be concordant (rs = 0.068) and any heritable factors controlling the major aspects of these phenomena do not co-segregate.This publication has 10 references indexed in Scilit:
- Genetic aspects of the polymodally distributed sulphoxidation of S‐ carboxymethyl‐L‐cysteine in man.British Journal of Clinical Pharmacology, 1984
- The genetic control of sparteine and debrisoquine metabolism in man with new methods of analysing bimodal distributions.Journal of Medical Genetics, 1983
- Spectral binding studies of the polymorphically metabolized drugs debrisoquine, sparteine and phenformin by cytochrome P-450 of normal and hydroxylation deficient rat strainsBiochemical Pharmacology, 1982
- Polymorphic sulphoxidation of S-carboxymethyl-L-cysteine in manBiochemical Pharmacology, 1982
- Genetic polymorphism of phenformin 4-hydroxylationClinical Pharmacology & Therapeutics, 1982
- GENETICALLY DETERMINED IMPAIRED DRUG SULPHOXIDATIONThe Lancet, 1981
- A family and population study of the genetic polymorphism of debrisoquine oxidation in a white British population.Journal of Medical Genetics, 1980
- Microsomal Cytochrome P-450: A Central Catalyst in Detoxication ReactionsPublished by Elsevier ,1980
- The metabolism of [14C]‐debrisoquine in man.British Journal of Clinical Pharmacology, 1979
- Biochemistry of Drug Oxidation and Reduction by Enzymes in Hepatic Endoplasmic ReticulumPublished by Elsevier ,1966